Stretch-induced inhibition of Wnt/β-catenin signaling in mineralizing osteoblasts

Journal of Orthopaedic Research

Volumn 28, Issue 3, 2010, Pages 390-396

  Jansen, Justus H W ^a   Eijken, Marco ^a   Jahr, Holger ^a   Chiba, Hideki ^b   Verhaar, Jan A N ^a   Van Leeuwen, Johannes P T M ^a   Weinans, Harrie ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Human osteoblast; Mechanical loading; Mineralization; Molecular pathways; Wnt signaling

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ALKALINE PHOSPHATASE; BETA CATENIN; CALCIUM; LUCIFERASE; WNT PROTEIN;

ARTICLE; BONE MINERALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MECHANOTRANSDUCTION; OSTEOBLAST; PRIORITY JOURNAL;

BETA CATENIN; BUTADIENES; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; DOWN-REGULATION; ENZYME INHIBITORS; GENES, REPORTER; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LITHIUM CHLORIDE; NITRILES; OSTEOBLASTS; PLASMIDS; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; STRESS, MECHANICAL; TIME FACTORS; TISSUE DISTRIBUTION; UP-REGULATION; WNT PROTEINS;

EID: 73949120437     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20991     Document Type: Article

References (47)

1. Nusse R. 2005. Wnt signaling in disease and in development. Cell Res 15:28-32.
2. Nusse R, Varmus HE. 1992. Wnt genes. Cell 69:1073-1087.
3. Gong Y, Slee RB, Fukai N, et al. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523.
4. Kato M, Patel MS, Levasseur R, et al. 2002. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157:303-314.
5. Boyden LM, Mao J, Belsky J, et al. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513-1521.
6. Sawakami K, Robling AG, Ai M, et al. 2006. The Wnt coreceptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J Biol Chem 281:23698-23711.
7. Chen Y, Whetstone HC, Lin AC, et al. 2007. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med 4:1216-1229.
8. Gregory CA, Gunn WG, Reyes E, et al. 2005. How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow. Ann NY Acad Sci 1049:97-106.
9. Johnson ML. 2004. The high bone mass family - the role of Wnt/Lrp5 signaling in the regulation of bone mass. J Musculoskelet Neuronal Interact 4:135-138.
10. Hens JR, Wilson KM, Daun P, et al. 2005. TOPGAL mice show that the canonical Wnt signaling pathway is active during bone development and growth and is activated by mechanical loading in vitro. J Bone Miner Res 20:1103-1113.
11. Armstrong VJ, Muzylak M, Sunters A, et al. 2007. Wnt/betacatenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha. J Biol Chem 282:20715-20727.
12. Lau KH, Kapur S, Kesavan C, et al. 2006. Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL/6J osteoblasts as opposed to C3H/HeJ osteoblasts in part contributes to the differential anabolic response to fluid shear. J Biol Chem 281:9576-9588.
13. Kamel M, Holladay B, Johnson ML. 2006. Potential interaction of prostaglandin and Wnt signaling pathways mediating bone cell responses to fluid flow. J Bone Miner Res 21:S92 (abstr. no. F166).
14. Case N, Ma M, Sen B, et al. 2008. beta-Catenin levels influence rapid mechanical responses in osteoblasts. J Biol Chem 283:29196-29205.
15. Kim JB, Leucht P, Lam K, et al. 2007. Bone regeneration is regulated by Wnt signaling. J Bone Miner Res 22:1913-1923.
16. de Boer J, Siddappa R, Gaspar C, et al. 2004. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 34:818-826.
17. Boland GM, Perkins G, Hall DJ, et al. 2004. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult humanmesenchymal stem cells. J Cell Biochem93:1210-1230.
18. Eijken M, Meijer IMJ, Westbrock I, et al. 2007. Wnt signaling acts and is regulated in a human osteoblast differentiation dependent manner. J Cell Biochem 104:568-579.
19. van der Horst G, van der Werf SM, Farih-Sips H, et al. 2005. Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells. J Bone Miner Res 20:1867-1877.
20. Kahler RA, Galindo M, Lian J, et al. 2006. Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts. J Cell Biochem 97:969-983.
21. Jansen JH, Weyts FA, Westbroek I, et al. 2004. Stretch-induced phosphorylation of ERK1/2 depends on differentiation stage of osteoblasts. J Cell Biochem 93:542-551.
22. Jessop HL, Rawlinson SC, Pitsillides AA, et al. 2002. Mechanical strain and fluid movement both activate extracellular regulated kinase (ERK) in osteoblast-like cells but via different signaling pathways. Bone 31:186-194.
23. Rubin J, Murphy TC, Zhu L, et al. 2003. Mechanical strain differentially regulates endothelial nitric-oxide synthase and receptor activator of nuclear kappa B ligand expression via ERK1/2 MAPK. J Biol Chem 278:34018-34025.
24. Peverali FA, Basdra EK, Papavassiliou AG. 2001. Stretch-mediated activation of selective MAPK subtypes and potentiation of AP-1 binding in human osteoblastic cells. Mol Med 7:68-78.
25. Karsten U, Wollenberger A. 1977. Improvements in the ethidium bromide method for direct fluorometric estimation of DNA and RNA in cell and tissue homogenates. Anal Biochem 77:464-470.
26. Lowry OH, Roberts NR, Wu M-L, et al. 1954. The quantitative histochemistry of brain. II. Enzyme measurements. J Biol Chem 207:19-27.
27. Weyts FA, Bosmans B, Niesing R, et al. 2003. Mechanical control of human osteoblast apoptosis and proliferation in relation to differentiation. Calcif Tissue Int 72:505-512.
28. Vande Geest JP, Di Martino ES, Vorp DA. 2004. An analysis of the complete strain field within Flexercell membranes. J Biomech 37:1923-1928.
29. Favata MF, Horiuchi KY, Manos EJ, et al. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632.
30. van de Wetering M, Cavallo R, Dooijes D, et al. 1997. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88:789-799.
31. Willert J, Epping M, Pollack JR, et al. 2002. A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2:8.
32. Wodarz A, Nusse R. 1998. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59-88.
33. Robinson JA, Chatterjee-Kishore M, Yaworsky PJ, et al. 2006. Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J Biol Chem 281:31720-31728.
34. Rawadi G, Vayssiere B, Dunn F, et al. 2003. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18:1842-1853.
35. Bennett CN, Longo KA, Wright WS, et al. 2005. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 102:3324-3329.
36. Day TF, Guo X, Garrett-Beal L, et al. 2005. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8:739-750.
37. Bodine PV, Billiard J, Moran RA, et al. 2005. The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis. J Cell Biochem 96:1212-1230.
38. Almeida M, Han L, Bellido T, et al. 2005. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem 280:41342-41351.
39. Bonewald LF, Johnson ML. 2008. Osteocytes, mechanosensing and Wnt signaling. Bone 42:606-615.
40. Arts J, Kuiper GG, Janssen JM, et al. 1997. Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology 138:5067-5070.
41. Chiba H, Sawada N, Ono T, et al. 1993. Establishment and characterization of a simian virus 40-immortalized osteoblastic cell line from normal human bone. Jpn J Cancer Res 84:290-297.
42. Janssen JM, Bland R, Hewison M, et al. 1999. Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function. J Cell Biochem 75:528-537.
43. Eijken M, Hewison M, Cooper MS, et al. 2005. 11beta-Hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation. Mol Endocrinol 19:621-631.
44. Nelson WJ, Nusse R. 2004. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483-1487.
45. Arnsdorf EJ, Tummala P, Jacobs CR. 2009. Non-canonical Wnt signaling and N-cadherin related beta-catenin signaling play a role in mechanically induced osteogenic cell fate. PLoS ONE 4:1-10.
46. Rubin CT, Lanyon LE. 1985. Regulation of bone mass by mechanical strain magnitude. Calcif Tissue Int 37:411-417.
47. Burr DB, Milgrom C, Fyhrie D, et al. 1996. In vivo measurement of human tibial strains during vigorous activity. Bone 18:405-410.